DAPT Score (Dual Antiplatelet Therapy) Calculator
Calculate the patient's score
Select each clinical or procedural feature. The score is intended to support reassessment after 12 months of dual antiplatelet therapy.
About the DAPT Score
The Dual Antiplatelet Therapy (DAPT) Score was developed to help estimate the balance of ischemic benefit and bleeding harm associated with continuing dual antiplatelet therapy beyond one year after coronary stent implantation. It is an aid to clinical decision-making, not a substitute for individualized assessment.
Score components
| Variable | Criterion | Points |
|---|---|---|
| Age | 75 years or older | −2 |
| Age | 65–74 years | −1 |
| Age | Younger than 65 years | 0 |
| Current cigarette smoking | Yes | +1 |
| Diabetes mellitus | Yes | +1 |
| MI at presentation | Yes | +1 |
| Prior PCI or MI | Yes | +1 |
| Stent diameter | Less than 3 mm | +1 |
| Paclitaxel-eluting stent | Yes | +1 |
| CHF or LVEF below 30% | Yes | +2 |
| Saphenous vein graft stent | Yes | +2 |
Interpreting the result
A score of 2 or greater was associated with a more favorable balance for extended DAPT in the score's derivation and validation cohorts; a score below 2 was associated with less favorable net benefit. The score does not quantify an individual's absolute risk and should not be used alone to prescribe or stop antiplatelet therapy.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.